Pharmacological issues relating to viral resistance

Infection

Volumn 27, Issue SUPPL. 2, 1999, Pages

  Back, D J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

CELL LEVEL; CONFERENCE PAPER; DOWN REGULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHOSPHORYLATION; PROTEIN EXPRESSION; VIRUS INFECTION;

ANTI-HIV AGENTS; DRUG RESISTANCE, MICROBIAL; HIV INFECTIONS; HUMANS; PHOSPHORYLATION; TREATMENT FAILURE; VIRAL PHYSIOLOGY; VIRUSES;

EID: 0032861071     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02561671     Document Type: Conference Paper

References (21)

1. Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., Holmberg, S. D.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338 (1998) 853-860.
2. Hogg, R. S., Heath, K. V., Yip, B., Craib, K. J. P., O'Shaughnessy, M. V., Schechter, M. T., Montaner, J. S. G.: Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 279 (1998) 450-454.
3. Lavie, A., Schlichting, I., Vetter, I. R., Konrad, M., Reinstein, J., Goody, R. S.: The bottleneck in AZT activation. Nature 3 (1947) 922-924.
4. Jacobsson, B., Britton, S., He, Q., Karlsson, A., Eriksson, S.: Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism. AIDS Res. Hum. Retroviruses 11 (1995) 805-811.
5. Sommadossi, J.-P., Zhou, X., Moore, J., Havlir, D. V., Fridland, G., Tierney, C, Smeaton, L., Fox, L., Richman, D., Pollard, R. and the ACTG 290 Team: Impairment of stavudine phosphorylation in patients receiving a combination of zidovudine and stavudine. Abstr.; 5th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, February 1998.
6. Back, D. J., Hoggard, P. G., Gibbons, S. E., Lloyd, J., Khoo, S. H., Wilkins, E. G., Merry, C., Barry, M. G., Dann, L., Loveday, C.: Zidovudine (ZDV) phosphorylation determined at intervals over 12 months in naive and antiretroviral experienced HIV+ patients. Abstr. 42260; 12th World AIDS Conference, Geneva, Switzerland, July 1998.
7. Arner, E. S. J., Valentin, A., Eriksson, S.: Thymidine and 3′-azido-3′-deoxythymidine metabolism in human peripheral blood lymphocytes and monocyte-derived macrophages. J. Biol. Chem. 267 (1992) 10968-10975.
8. Phiboonbanakit, D., Lloyd, J., Khoo, S., Wilkins, E., Maher, B., Barry, M., Back, D.: Quantification of d4T triphosphate in ZDV naive and ZDV experienced HIV infected individuals by an enzymatic assay. Abstr.; 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, February 1999.
9. Gao, W, Y., John, D. G., Mitsuya, H.: Anti-human immunodeficiency virus type 1 activity of hydroxyurea in combination with 2′,3′-dideoxynucleosides. Mol. Pharmacol. 46 (1994) 767-772.
10. Gottesman, M. M., Pastan, I.: Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem. 62 (1993) 385-427.
11. Kim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J. J., Roden, D. M., Wilkinson, G. R.: The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin. Invest. 101 (1998) 289-294.
12. Lee, C. G. L., Gottesman, M. M., Cardarelli, C. O., Ramachandra, M., Jeang, K. T., Ambudkar, S. V., Pastan, I., Dey, S.: HIV-1 protease inhibitors are substrates for the MDR-1 multidrug transporter. Biochem. J. 37 (1998) 3594-3601.
13. Washington, C. B., Duran, G. E., Sikic, B. I., Blaschke, T. F.: Saquinavir is a high affinity substrate for the multidrug transporter P-glycoprotein. Clin. Priarmacol.Ther. 61 (1997) 193.
14. Srinivas, R. V., Middlemas, D., Flynn, P., Fridland, A.: Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters. Antimicrob. Agents Chemother. 42 (1998) 3157-3162.
15. Washington, C. B., Duran, G. E., Man, M. C., Sikic, B. I., Blaschke, T. F.: Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells. Acquir. Immune Defic. Syndr. Human Retrovirol. 19 (1998) 203-209.
16. Profit, L., Brooks, B., Williams, D. P., Back, D. J.: Modulation of P-glycoprotein function in human peripheral mononuclear cells by saquinavir. Br. J. Clin. Pharmacol. 46 (1998) 295P.
17. Drach, D., Zhao, S., Drach, J., Mahadevia, R., Gattringer, C., Huber, H., Andreeff, M.: Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80 (1992) 2729-2734.
18. Lucia, M. B., Cauda, R., Landay, A. L., Malorni, W., Donelli, G.: Transmembrane P-glycoprotein (P-gp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug unrelated function. AIDS Res. Hum. Retroviruses 11 (1995) 893-901.
19. Kaczorowski, S., Ochocka, M., Kaczorowska, M., Aleksandrowicz, R., Matysiakl, M., Karwacki, M.: Is P-glycoprotein a sufficient marker for multidrug resistance in vivo - immunohistochemical staining for P-glycoprotein in children and adult leukaemia. Leuk. Lymphoma 20 (1995) 143-152.
20. Kobayashi, Y., Wantanabe, N., Oshimi, K.: Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte proliferative disorders. Leuk. Lymphoma 14 (1994) 157-161.
21. Goldstein, L. J., Pastan, I., Gottesman, M. M.: Multidrug resistance in human cancer. Crit. Rev. Oncol. Hematol. 12 (1992) 243-253.